Skip to main content
Equibles

NYXH · Nyxoah SA

Track NYXH — free

Use NYXH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NYXH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.54 +0.04 (+2.67%) At close · Sep 11
Rebalance outlook locked
Market Cap
$156.83M
Shares
101.84M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.54 Open$1.54 Day$1.51–1.57 52W close$1.31–6.52 Avg vol 30d414K Short int244K · 0.2% float · 2.3d Short vol59% Last earningsAug 5, 2026 DataApr 2021–Sep 2026

Up next

Next earnings call
Oct 30, 2026 Est · unconfirmed · in 7 wks

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+15.0%
Year over year · more shares
Price change (1Y)
-73.1%
Trailing year
Short interest
0.2%
Latest settlement · 2.3 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.60
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −51%
below
Price vs 50-day avg −1%
below
RSI (14) 48
neutral
MACD trend Negative
52-week position 4%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −3%
trailing
6-month return −50%
trailing
YTD return −67%
this year
Relative strength −68%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow Accumulating
+32% holders QoQ · +20 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.24% of float · ▼ -48.5% MoM · 2.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
45 holders — near 3-yr high, broad support
Squeeze score 32
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 84%
annualized · 1-yr
Max drawdown −80%
past year
ATR 6.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jun 30, 2026
Gross margin · full year 2026 Initiated 60% – 62%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−51% Bearish
Price vs 50-day avg
−1% Neutral
RSI (14)
48 Neutral
MACD trend
Negative Bearish
52-week position
4% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow Accumulating
+32% holders QoQ · +20 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.24% of float · ▼ -48.5% MoM · 2.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
45 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $2 · 4% Range high $7
vs 200-day avg -51% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NYXH
Nyxoah SA
this stock
$156.83M -66.5% — — 0.2%
ABT
Abbott Laboratories
 $177.58B -18.6% +5.7% 28.6 1.3%
MDT
Medtronic plc
 $116.35B -5.3% +8.4% 22.4 0.9%
SYK
Stryker Corp
 $105.70B -21.6% +11.2% 28.6 2.0%
BSX
Boston Scientific Corp
 $62.29B -54.9% +12.5% 17.4 3.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
45
% held
21.7%
Net QoQ
+18.5M sh
Top holder
AIGH Capital Management L…
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Falling
Shares short
244.3K
Days to cover
2.3d
Change
-230.4K sh
View
Short Volume
Short vol %
59%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
326
Value
$460
As of
Aug 6, 2026
View
Off-Exchange
Off-exchange %
45.3%
Week of
Aug 3, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 5, 2026
This year
12
View
Earnings & Events
Earnings Calls
Last call
Aug 5, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
NYXH -12.5% -2.5% -50.0% -1.3% -66.5%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -11.4% -0.8% -67.8% -0.9% -78.6%
Key facts CIK 1857190 CUSIP B6S7WD106 13F (30d) 26 filings 26 filers Visit website Investor relations